Elective coronary stenting 1109

..
27. Kerneis M, Silvain J, Montalescot G; ACTION Study Group. Cangrelor: fixing life .. the European Association of Percutaneous Cardiovascular Interventions
or just a leak? JACC Cardiovasc Interv 2016;9:1914–1916. .. (EAPCI). Eur Heart J 2014;35:2541–2619.
28. Mehran R, Ambrose JA, Bongu RM, Almeida OD, Israel DH, Torre S, Sharma SK, .. 30. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati
Ratner DE. Angioplasty of complex lesions in ischemic rest angina: results of the .. A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG,
Thrombolysis and Angioplasty in Unstable Angina (TAUSA) trial. J Am Coll .. Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group; ESC
Cardiol 1995;26:961–966. .. Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017
29. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm
.. ESC focused update on dual antiplatelet therapy in coronary artery disease
..
C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, .. developed in collaboration with EACTS: the Task Force for dual antiplatelet
Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, .. therapy in coronary artery disease of the European Society of Cardiology (ESC)
Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS guidelines .. and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur
on myocardial revascularization: the Task Force on Myocardial Revascularization .. Heart J 2018;39:213–254.
of the European Society of Cardiology (ESC) and the European Association for .. 31. Silvain J, Kerneis M, Montalescot G. Potent P2Y12 inhibitors in low-risk patients:
Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of .. is there a medical need? J Am Coll Cardiol 2016;67:614–617.

Downloaded from https://academic.oup.com/eurheartj/article-abstract/39/13/1109/3091135 by guest on 01 February 2020

Corrigendum doi:10.1093/eurheartj/ehx039
Online publish-ahead-of-print 27 March 2017
....................................................................................................................................................
Corrigendum to: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS [Eur Heart J
(2016);37(38): 2893–2962].
The publisher wishes to inform readers that corrections have been made to table 14 and 17 to amend mL/dL to mL/min in the following
places:

Table 14, row Percentage of patients with CKD, column Apixaban

Table 17, row Flecainide, column Main contra-indications and precautions

Table 17, row d,l sotalol, column Main contra-indications and precautions.
The paper has now been corrected online.

Published on behalf of the European Society of Cardiology. All rights reserved. V

C The Author 2017. For permissions, please email: journals.permissions@oup.com.